Chi-Feng Liu

850 total citations · 1 hit paper
31 papers, 683 citations indexed

About

Chi-Feng Liu is a scholar working on Physiology, Public Health, Environmental and Occupational Health and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Chi-Feng Liu has authored 31 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Physiology, 7 papers in Public Health, Environmental and Occupational Health and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Chi-Feng Liu's work include Heart Rate Variability and Autonomic Control (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Acupuncture Treatment Research Studies (3 papers). Chi-Feng Liu is often cited by papers focused on Heart Rate Variability and Autonomic Control (5 papers), Drug-Induced Hepatotoxicity and Protection (4 papers) and Acupuncture Treatment Research Studies (3 papers). Chi-Feng Liu collaborates with scholars based in Taiwan, United Kingdom and Russia. Chi-Feng Liu's co-authors include Po‐Lin Kuo, Chun‐Ching Lin, Ya‐Ling Hsu, Edmund Cheung So, Mei‐Ling Yeh, Pao‐Luh Tao, Song-Chow Lin, Hsing‐Hsia Chen, Jiu‐Yao Wang and K.B.M. Reid and has published in prestigious journals such as Nutrients, Life Sciences and European Journal of Pharmacology.

In The Last Decade

Chi-Feng Liu

28 papers receiving 659 citations

Hit Papers

Predictive Role of Neutrophil-Percentage-to-Albumin Ratio... 2023 2026 2024 2025 2023 25 50 75

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chi-Feng Liu Taiwan 16 147 126 124 110 75 31 683
Şemsettin Şahin Türkiye 20 246 1.7× 97 0.8× 135 1.1× 58 0.5× 54 0.7× 41 1.1k
Yueh‐Ting Tsai Taiwan 17 217 1.5× 195 1.5× 67 0.5× 195 1.8× 50 0.7× 48 803
Fahaid Al‐Hashem Saudi Arabia 16 202 1.4× 64 0.5× 125 1.0× 63 0.6× 111 1.5× 70 819
Beom‐Joon Lee South Korea 17 259 1.8× 209 1.7× 109 0.9× 124 1.1× 36 0.5× 104 844
Thomas Moeslinger Austria 17 245 1.7× 80 0.6× 83 0.7× 44 0.4× 35 0.5× 32 888
Xuedong An China 17 339 2.3× 195 1.5× 173 1.4× 101 0.9× 130 1.7× 48 1.1k
Elisa Mieko Suemitsu Higa Brazil 21 213 1.4× 134 1.1× 221 1.8× 77 0.7× 74 1.0× 60 1.1k
Arshad Jahangir United States 15 299 2.0× 274 2.2× 108 0.9× 71 0.6× 85 1.1× 51 1.2k
Pai‐Feng Kao Taiwan 14 118 0.8× 83 0.7× 69 0.6× 74 0.7× 93 1.2× 21 648

Countries citing papers authored by Chi-Feng Liu

Since Specialization
Citations

This map shows the geographic impact of Chi-Feng Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chi-Feng Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chi-Feng Liu more than expected).

Fields of papers citing papers by Chi-Feng Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chi-Feng Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chi-Feng Liu. The network helps show where Chi-Feng Liu may publish in the future.

Co-authorship network of co-authors of Chi-Feng Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Chi-Feng Liu. A scholar is included among the top collaborators of Chi-Feng Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chi-Feng Liu. Chi-Feng Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Au, Heng‐Kien, et al.. (2024). Clinical factors associated with subsequent surgical intervention in women undergoing early medical termination of viable or non-viable pregnancies. Frontiers in Medicine. 11. 1188629–1188629. 1 indexed citations
2.
Liu, Chi-Feng, et al.. (2023). Triglyceride glucose index and poor sleep patterns in non-diabetic adults: Evidence from NHANES 2005–2016. Frontiers in Nutrition. 10. 1051667–1051667. 11 indexed citations
4.
Liu, Chi-Feng, et al.. (2023). Predictive Role of Neutrophil-Percentage-to-Albumin Ratio (NPAR) in Nonalcoholic Fatty Liver Disease and Advanced Liver Fibrosis in Nondiabetic US Adults: Evidence from NHANES 2017–2018. Nutrients. 15(8). 1892–1892. 77 indexed citations breakdown →
5.
Wu, Yu‐Sheng, et al.. (2015). Mushroomβ-Glucan May Immunomodulate the Tumor-Associated Macrophages in the Lewis Lung Carcinoma. BioMed Research International. 2015. 1–15. 27 indexed citations
6.
Au, Heng‐Kien, et al.. (2015). Association between ultrasonographic parameters of Cesarean scar defect and outcome of early termination of pregnancy. Ultrasound in Obstetrics and Gynecology. 47(4). 506–510. 7 indexed citations
7.
Wu, Yu‐Sheng, et al.. (2014). Oral Administration of MBG to Modulate Immune Responses and Suppress OVA‐Sensitized Allergy in a Murine Model. Evidence-based Complementary and Alternative Medicine. 2014(1). 567427–567427. 8 indexed citations
8.
Liu, Chi-Feng, et al.. (2009). Transcutaneous Electrical Stimulation of Acupoints Changes Body Composition and Heart Rate Variability in Postmenopausal Women with Obesity. Evidence-based Complementary and Alternative Medicine. 2011(1). 862121–862121. 11 indexed citations
9.
Liu, Chi-Feng, et al.. (2005). Therapeutic effect of surfactant protein D in allergic inflammation of mite‐sensitized mice. Clinical & Experimental Allergy. 35(4). 515–521. 40 indexed citations
10.
Liu, Chi-Feng, et al.. (2005). Mite allergen induces nitric oxide production in alveolar macrophage cell lines via CD14/toll‐like receptor 4, and is inhibited by surfactant protein D. Clinical & Experimental Allergy. 35(12). 1615–1624. 28 indexed citations
11.
Sun, Mao-Feng, Hui‐Chi Huang, Song-Chow Lin, Liping Chang, & Chi-Feng Liu. (2005). Evaluation of nitric oxide and homocysteine levels in primary dysmenorrheal women in Taiwan. Life Sciences. 76(17). 2005–2009. 25 indexed citations
12.
Yeh, Mei‐Ling, Hsing‐Hsia Chen, Edmund Cheung So, & Chi-Feng Liu. (2004). A study of serum malondialdehyde and interleukin-6 levels in young women with dysmenorrhea in Taiwan. Life Sciences. 75(6). 669–673. 46 indexed citations
13.
Hsu, Ya‐Ling, Po‐Lin Kuo, Chi-Feng Liu, & Chun‐Ching Lin. (2004). Acacetin-induced cell cycle arrest and apoptosis in human non-small cell lung cancer A549 cells. Cancer Letters. 212(1). 53–60. 105 indexed citations
14.
Yeh, Mei‐Ling, et al.. (2003). Hepatoprotective Effect of <i>Angelica archangelica</i> in Chronically Ethanol-Treated Mice. Pharmacology. 68(2). 70–73. 22 indexed citations
15.
So, Edmund Cheung, et al.. (2002). Tetramethylpyrazine protects mice against thioacetamide-induced acute hepatotoxicity. Journal of Biomedical Science. 9(5). 410–414. 37 indexed citations
16.
Liu, Chi-Feng, et al.. (2002). Protective Effect of Tetramethylpyrazine on Absolute Ethanol-Induced Renal Toxicity in Mice. Journal of Biomedical Science. 9(4). 299–302. 4 indexed citations
17.
Liu, Chi-Feng, Lai‐Chu See, & Ying‐Tung Lau. (1996). Microcirculatory vasoconstrictor response: Relationship with vital capacity and smoking. Life Sciences. 59(13). 1031–1037. 2 indexed citations
18.
Tao, Pao‐Luh, et al.. (1995). Chronic intracerebroventricular administration of morphine down-regulates spinal adenosine A1 receptors in rats. European Journal of Pharmacology. 278(3). 233–237. 14 indexed citations
19.
Lau, Ying‐Tung, Chi-Feng Liu, & Chin‐Feng Tsai. (1995). Cutaneous Vasoconstrictor Response Induced by Inspiratory Gasp in Relation to Sex and Age. Clinical Science. 89(3). 233–237. 10 indexed citations
20.
Tao, Pao‐Luh & Chi-Feng Liu. (1992). Chronic morphine treatment causes down-regulation of spinal adenosine A1 receptors in rats. European Journal of Pharmacology. 215(2-3). 301–304. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026